PLSE

Pulse Biosciences, Inc.
CAPPED RATING

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company\'s proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.

Pulse Biosciences, Inc. (PLSE) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B+); its weakest is Value (F).

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
F
Factor Score 0.0 / 5.0
Growth
B+
Factor Score 3.8 / 5.0
Profitability
C-
Factor Score 2.1 / 5.0
Momentum
B
Factor Score 3.5 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -43.6
EV / EBITDA -40.8
Rev Growth YoY 359.3%
Gross Margin 26.8%
Price Return 3M 7.8%
Price Return 12M 236.3%
Catalyst Signal 0.00
Market Cap $3.7B
TTM Revenue $1.5M
Price / Sales 2.5K
ROE -60.6%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 F (0.0) B+ (3.8) C- (2.1) B (3.5) C+ (2.6) C (2.4)
2026-11-07 F (0.0) B+ (3.8) C (2.3) A- (3.9) C+ (2.7) C+ (2.5)
2026-10-31 F (0.0) B (3.2) D+ (1.6) A- (4.1) C+ (2.7) C (2.3)
2026-10-24 F (0.0) B (3.2) D+ (1.6) A+ (4.5) C+ (2.6) C (2.4)
2026-10-17 F (0.0) B (3.2) D+ (1.6) A+ (4.6) C+ (2.6) C (2.4)
Page 1 of 5